Friday, May 01, 2015 9:19:25 AM
> Per the radio interview, partnerships with multi-billion dollar companies are coming down the pipe. [http://thestockradio.com/admd-advanced-medical-isotope-corp-ceo-james-katzaroff/]
----> List of Multi-billion dollar Pharma companies of 2014 [http://www.forbes.com/sites/matthewherper/2015/01/04/grading-pharma-in-2014-17-drug-companies-ranked/]
> Per the PR's, we're awaiting an FDA approval [http://www.isotopeworld.com/2014/12/23/advanced-medical-isotope-corporation-files-a-de-novo-submission-for-y-90-radiogel-tm-device/]
----> Per the latest PR, there wasnt any mention of waiting on word from the FDA besides the ADMD profile which gets pull from the website. I believe they have a response [https://www.accesswire.com/428387/Advanced-Medical-Isotope-Corporation-Provides-Additional-Update-on-Strategic-Plan]
> Per the PR's, we are eliminating debt and decreasing the share structure without doing any reverse splits. Balance sheets will show a tremendous debt decrease come Q2 financials [http://www.isotopeworld.com/2015/04/23/advanced-medical-isotope-corporation-initiates-capital-restructuring-plan/][https://www.accesswire.com/428387/Advanced-Medical-Isotope-Corporation-Provides-Additional-Update-on-Strategic-Plan]
> Per the latest form 4, insiders are still buying shares, which is always a great sign[http://archive.fast-edgar.com//20150430/AN25T22CZC22I2DZ272S2C325RKOZC22Z272/]
> Per a 2014 slide from ADMD, we seem to be reaching our goals step by step. [Slide 16][http://www.slideshare.net/cameronbond/amic-overview-jan-2014-30029233]
Opinion: FDA Approval equals $0.05 minimum.
Examples:
$DNDNQ
April 13th, 2009: On news of the Phase III clinical trial of it’s prostate cancer drug (Provenge) being successful, Dendreon Corp’s (a leader in cancer drug research) stock price sky-rocketed from $7.30 to $18.85.
This represents an increase of 158% in just one day
This would mean that if you had invested $100,000 in DNDN on April 12th, 2009, you would have had close to $258,000 the next day!
$VNDA
May 7th, 2009: Vanda Pharmaceuticals Inc. announces the FDA approval of its schizophrenia drug, Fanapta. This caused the company’s stock to multiple nearly 8 times from $1.08 to $8.80.
That is an increase of just over 714%!
Again, this would mean that if you had invested $100,000 in VNDA on May 6th, 2009, you would have had over $814,000 the next day!
Now I know the above doesn't happen for all stocks but we're in sub penny's where FDA approvals are like Bigfoot, talked about but never seen.
I watched $ADMD run to 0.0041 from 0.0031 within 4 minutes after the PR about restructuring [April 23rd-24th]. Can you imagine if it were FDA approval news? I can. Multiple pennies within an hour.This stock will reach $0.10. And when it does, we will break and see 0.25+.
Now is the time to decide whether you want to be the nail or the hammer.
Disclaimer: The statement above is my personal opinion and are not facts unless supported by legitimate documentation or material. Please do your own due diligence regarding this security. I have never been paid or compensated by anyone for any stock I've
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM